About this trial
The primary objective of this study is to evaluate whether a management strategy based on coronary computed tomography angiography (CCTA) for patients with non-obstructive coronary artery disease can improve the LDL-C target achievement rate compared to a traditional management strategy without follow-up CCTA, thereby reducing the incidence of major adverse cardiovascular and cerebrovascular events over a 3 years period, including all-cause mortality, myocardial infarction, ischemia driven revascularation and stroke.
Eligibility criteria
Qualifiers
Age between 18 and 80 years old;
Known patients with non-obstructive coronary artery disease (disease duration ≥2 years);
Patients who agree to undergo follow-up CCTA examinations and cooperate in completing follow-up observations.
Disqualifiers
Patients who have experienced ACS or PCI/CABG;
Patients who have experienced adverse cardiovascular and cerebrovascular events;
Patients who have undergone follow-up CCTA or DSA examinations before enrollment;
Patients with severe hepatic and renal dysfunction;
Trial design
Treatments tested in this trial
- Coronary Computed Tomography Angiography
- Current clinical guidelines
Treatment groups
Sponsors and collaborators
Zhang longjiang,MD
Lead sponsor
Jinling Hospital, China
Sponsor institution